Literature DB >> 9671068

Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program.

W E Longo1, K S Virgo, F E Johnson, T P Wade, A M Vernava, M A Phelan, W G Henderson, J Daley, S F Khuri.   

Abstract

OBJECTIVE: To define risk factors that predict adverse outcomes after proctectomy for cancer in Department of Veterans Affairs Medical Centers. SUMMARY BACKGROUND DATA: Accurate presurgical assessment of the risk of perioperative complications and death is important in planning surgical therapy.
METHODS: The National VA Surgical Quality Improvement Program contains prospectively collected and extensively validated data on >287,000 patients. All patients undergoing proctectomy for rectal cancer from 1991 to 1995 who were registered in this data base were selected for study. Independent variables examined included 68 presurgical and 12 intraoperative clinical risk factors; dependent variables were 21 specific adverse outcomes. Stepwise logistic regression analysis was used to construct models predicting 30-day morbidity rates for each of the 10 most common complications and the 30-day mortality rate.
RESULTS: Five hundred ninety-one patients were identified; 467 (79%) underwent abdominoperineal resection and 124 (21%) were treated with sphincter-saving procedures. Thirty percent of patients had one or more complications after proctectomy. Prolonged ileus, urinary tract infection, pneumonia, and deep wound infection were the most frequently reported complications. The 30-day mortality rate was 3.2% (19 deaths). For most complications, 30-day mortality rates were significantly higher for patients with complications than for those without. Thirty-day mortality rates for several complications exceeded 50%: cardiac arrest requiring cardiopulmonary resuscitation, deep venous thrombosis or thrombophlebitis, coma lasting >24 hours, acute renal failure, cerebrovascular accident, and pulmonary embolism. Four presurgical factors predicted a high risk of 30-day mortality in the logistic regression analysis: elevated blood urea nitrogen level, impaired sensorium, low serum albumin concentration, and partial thromboplastin time < or =25 seconds.
CONCLUSIONS: Mortality rates after proctectomy in VA hospitals are comparable to those reported in other large series. Most postsurgical complications are associated with an increased 30-day mortality rate. Elevated presurgical blood urea nitrogen level, impaired sensorium, low serum albumin concentration, and partial thromboplastin time < or =25 seconds predict a high risk of 30-day mortality.

Entities:  

Mesh:

Year:  1998        PMID: 9671068      PMCID: PMC1191429          DOI: 10.1097/00000658-199807000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

1.  Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery.

Authors:  F L Grover; K E Hammermeister; C Burchfiel
Journal:  Ann Thorac Surg       Date:  1990-07       Impact factor: 4.330

2.  Regression analyses of prognostic factors in colorectal cancer.

Authors:  E Hannisdal; G Thorsen
Journal:  J Surg Oncol       Date:  1988-02       Impact factor: 3.454

3.  Regression analysis of prognostic factors in colorectal cancer after curative resections.

Authors:  T Wiggers; J W Arends; A Volovics
Journal:  Dis Colon Rectum       Date:  1988-01       Impact factor: 4.585

4.  Emergency presentation and mortality from colorectal cancer in the elderly.

Authors:  R P Waldron; I A Donovan; J Drumm; S N Mottram; S Tedman
Journal:  Br J Surg       Date:  1986-03       Impact factor: 6.939

5.  Perioperative blood transfusion increases the risk of recurrence in colorectal cancer.

Authors:  J Beynon; P W Davies; P J Billings; J L Channer; D Protheroe; H C Umpleby; N J Mortensen; R C Williamson
Journal:  Dis Colon Rectum       Date:  1989-11       Impact factor: 4.585

6.  Outcome of colorectal cancer.

Authors:  M Pescatori; C Mattana; G Maria; A Ferrara; L Lucibello
Journal:  Br J Surg       Date:  1987-05       Impact factor: 6.939

7.  Predictors of survival after curative resection of carcinoma of the colon and rectum.

Authors:  M R Griffin; E J Bergstralh; R J Coffey; R W Beart; L J Melton
Journal:  Cancer       Date:  1987-11-01       Impact factor: 6.860

8.  Operative mortality following surgery for colorectal cancer.

Authors:  J L Canivet; P Damas; C Desaive; M Lamy
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

9.  Perforative carcinoma of colon and rectum.

Authors:  J P Welch; G A Donaldson
Journal:  Ann Surg       Date:  1974-11       Impact factor: 12.969

10.  Changing survival prospects in rectal carcinoma. A series of 1,306 patients managed by one surgeon.

Authors:  F T McDermott; E S Hughes; E A Pihl; W R Johnson; A L Polglase; B A Milne; H Katrivessis
Journal:  Dis Colon Rectum       Date:  1986-12       Impact factor: 4.585

View more
  22 in total

1.  Transanal endoscopic video-assisted (TEVA) excision.

Authors:  Madhu Ragupathi; Dominique Vande Maele; Javier Nieto; T Bartley Pickron; Eric M Haas
Journal:  Surg Endosc       Date:  2012-06-23       Impact factor: 4.584

2.  Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision.

Authors:  Radhika K Smith; Robert D Fry; Najjia N Mahmoud; E Carter Paulson
Journal:  Int J Colorectal Dis       Date:  2015-03-19       Impact factor: 2.571

3.  Reoperation as a quality indicator in colorectal surgery: a population-based analysis.

Authors:  Arden M Morris; Laura-Mae Baldwin; Barbara Matthews; Jason A Dominitz; William E Barlow; Sharon A Dobie; Kevin G Billingsley
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

Review 4.  The clinical results of the Turnbull-Cutait delayed coloanal anastomosis: a systematic review.

Authors:  J Hallet; H Milot; S Drolet; E Desrosiers; R C Grégoire; A Bouchard
Journal:  Tech Coloproctol       Date:  2014-03-11       Impact factor: 3.781

5.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.

Authors:  Donald C McMillan; Joseph E M Crozier; Khalid Canna; Wilson J Angerson; Colin S McArdle
Journal:  Int J Colorectal Dis       Date:  2007-01-24       Impact factor: 2.571

6.  Determinants of long-term survival after major surgery and the adverse effect of postoperative complications.

Authors:  Shukri F Khuri; William G Henderson; Ralph G DePalma; Cecilia Mosca; Nancy A Healey; Dharam J Kumbhani
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

7.  Colorectal stenting in England: a cross-sectional study of practice.

Authors:  J Lam; V Chauhan; I Lam; L Kannappa; Y Salama
Journal:  Ann R Coll Surg Engl       Date:  2020-04-29       Impact factor: 1.891

8.  British Society of Gastroenterology/Association of Coloproctologists of Great Britain and Ireland guidelines for the management of large non-pedunculated colorectal polyps.

Authors:  Matthew D Rutter; Amit Chattree; Jamie A Barbour; Siwan Thomas-Gibson; Pradeep Bhandari; Brian P Saunders; Andrew M Veitch; John Anderson; Bjorn J Rembacken; Maurice B Loughrey; Rupert Pullan; William V Garrett; Gethin Lewis; Sunil Dolwani
Journal:  Gut       Date:  2015-06-23       Impact factor: 23.059

9.  Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.

Authors:  Yuji Toiyama; Chikao Miki; Yasuhiro Inoue; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

10.  The association of pretreatment health-related quality of life with surgical complications for patients undergoing open surgical resection for colorectal cancer.

Authors:  Thomas Anthony; Linda S Hynan; Douglas Rosen; Lawrence Kim; Fiemu Nwariaku; Charlene Jones; George Sarosi
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.